₹92
(Inclusive of all Taxes)
₹13.8 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
वोन इंटरनेशनल
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इसके बाद या इसके बाद समाप्त हो रहा है :
Jan-27
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Lini-SP Tablet:
Co-administration of Lini-SP Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Lini-SP Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Co-administration of Lini-SP Tablet with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Lini-SP Tablet is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Severe
How does the drug interact with Lini-SP Tablet:
Co-administration of Lini-SP Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Lini-SP Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Lini-SP Tablet and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Lini-SP Tablet and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacSulindac
Severe
How does the drug interact with Lini-SP Tablet:
Co-administration of Lini-SP Tablet and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Lini-SP Tablet and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Lini-SP Tablet and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Lini-SP Tablet and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Lini-SP Tablet:
Co-administration of Lini-SP Tablet with Celecoxib may increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Although there is a interaction between Lini-SP Tablet and Celecoxib, but it can be taken if your doctor has advised it. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Do not discontinue any medication without consulting a doctor.
Co-administration of Lini-SP Tablet with Celecoxib may increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Although there is a interaction between Lini-SP Tablet and Celecoxib, but it can be taken if your doctor has advised it. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Do not discontinue any medication without consulting a doctor.
How does the drug interact with Lini-SP Tablet:
Co-administration of Lini-SP Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Lini-SP Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
Co-administration of Lini-SP Tablet with tenofovir disoproxil may increase the risk of developing kidney problems.
How to manage the interaction:
There may be a possible interaction between Lini-SP Tablet and Tenofovir disoproxil but they can be taken together if your doctor has prescribed them. However consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without first talking to your doctor.
How does the drug interact with Lini-SP Tablet:
Concomitant use of Lini-SP Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Lini-SP Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Concomitant use of Lini-SP Tablet with dabigatran may increase the risk of stomach bleeding.
How to manage the interaction:
Taking Lini-SP Tablet with dabigatran together possibly results in an interaction, it can be taken if your doctor has advised it. You should consult a doctor immediately if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as dizziness, light headedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache and weakness. Do not stop using any medications without first talking to your doctor.
Severe
How does the drug interact with Lini-SP Tablet:
Taking acalabrutinib together with Lini-SP Tablet may increase the risk of bleeding.
How to manage the interaction:
Co-administration of Lini-SP Tablet and Acalabrutinib can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Taking acalabrutinib together with Lini-SP Tablet may increase the risk of bleeding.
How to manage the interaction:
Co-administration of Lini-SP Tablet and Acalabrutinib can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Lini-SP Tablet:
Taking Lini-SP Tablet with Tolmetin may increase the risk of side effects.
How to manage the interaction:
There may be a possible interaction between Lini-SP Tablet and Tolmetin but can be taken if prescribed by doctor. However, consult your doctor immediately if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medications without consulting a doctor.
Taking Lini-SP Tablet with Tolmetin may increase the risk of side effects.
How to manage the interaction:
There may be a possible interaction between Lini-SP Tablet and Tolmetin but can be taken if prescribed by doctor. However, consult your doctor immediately if you experience any unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medications without consulting a doctor.
Severe
How does the drug interact with Lini-SP Tablet:
Coadministration of Lini-SP Tablet with cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Although taking Lini-SP Tablet and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Coadministration of Lini-SP Tablet with cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Although taking Lini-SP Tablet and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Lini-SP Tablet:
Taking Lini-SP Tablet with human immunoglobulin may increase the risk of kidney problems.
How to manage the interaction:
Although there is an interaction between Human immunoglobulin and Lini-SP Tablet, you can take these medicines together if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Taking Lini-SP Tablet with human immunoglobulin may increase the risk of kidney problems.
How to manage the interaction:
Although there is an interaction between Human immunoglobulin and Lini-SP Tablet, you can take these medicines together if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
असुरक्षित
एसपी टैबलेट 10'एस-लाइन लेते समय शराब के सेवन से बचें क्योंकि इससे अधिक उनींदापन हो सकता है।
गर्भावस्था
सावधानी
यदि आप गर्भवती हैं तो कृपया अपने चिकित्सक से परामर्श करें; आपका डॉक्टर एसपी टैबलेट 10'एस-लाइन तभी लिखेगा जब लाभ जोखिमों से अधिक हों।
स्तनपान
सावधानी
यदि आप स्तनपान करा रही हैं तो अपने डॉक्टर से सलाह लें; आपका डॉक्टर तय करेगा कि स्तनपान कराने वाली माताएं एसपी टैबलेट 10'एस-लाइन ले सकती हैं या नहीं।
ड्राइविंग
सावधानी
एसपी टैबलेट 10'एस-लाइन से चक्कर आना और उनींदापन हो सकता है। जब तक आप सतर्क न हों तब तक गाड़ी न चलाएं और न ही मशीनरी चलाएं।
जिगर
सावधानी
लीवर की समस्या वाले मरीजों में खुराक समायोजन की आवश्यकता हो सकती है। यदि आपको लीवर की कोई समस्या है या इस बारे में कोई चिंता है तो कृपया अपने चिकित्सक से परामर्श करें।
गुर्दा
सावधानी
किडनी की समस्या वाले मरीजों में खुराक समायोजन की आवश्यकता हो सकती है। अगर आपको किडनी की कोई समस्या है या इस बारे में कोई चिंता है तो कृपया अपने डॉक्टर से सलाह लें।
बच्चे
असुरक्षित
10 साल से कम उम्र के बच्चों को एसपी टैबलेट 10'एस-लाइन नहीं दिया जाना चाहिए, क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
